For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

5-Amino-1MQ Dosage Chart & Schedule

A small-molecule inhibitor of the enzyme NNMT — not a peptide — studied mainly in cell and animal models for its effects on fat-cell metabolism and its potential to preserve NAD+.

Route
Oral
Frequency
Once daily
Half-life
Not well characterized in humans
Storage
Store capsules cool, dry, and sealed away from light.
The short answer

5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide, taken by mouth rather than injected. Its effects on fat-cell metabolism come from cell and animal studies; research-community sources reference oral doses in the tens-of-milligrams range, with no validated human dosing.

Figures describe how 5-Amino-1MQ is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Starter
50 mg
Taken as an oral capsule, typically once daily.
Frequency
Once daily
Weekly total
~350 mg/week
Cycle
No established cycle

Low end of the oral doses cited in research communities.

Most commonStandard
100 mg
Taken as an oral capsule, typically once daily.
Frequency
Once daily
Weekly total
~700 mg/week
Cycle
No established cycle

A commonly cited mid oral dose; unvalidated in humans.

Maintenance
150 mg
Taken as an oral capsule, typically once daily.
Frequency
Once daily
Weekly total
~1,050 mg/week
Cycle
No established cycle

Upper end of the tens-of-milligrams range cited in research communities.

Not a peptide

  • 5-Amino-1MQ is a small-molecule NNMT inhibitor taken orally, not a reconstituted injectable peptide.
  • By inhibiting NNMT it is proposed to shift adipocyte metabolism and spare NAD+.

Preclinical evidence

  • Effects on fat metabolism come from cell and animal studies; there is no established human clinical dosing.

Ready to run this protocol?

Dosing is only as good as the vial. Research-grade peptides are third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

Weekly schedule

A typical week on the standard protocol (Once daily).

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Dosing day Off

Handling & storage

  • Supplied as oral capsules, not a reconstituted injectable, so no bacteriostatic water is involved.
  • Research-community sources take it once daily, often with food; there is no validated human regimen.
  • Store capsules in a cool, dry, sealed container away from light.

5-Amino-1MQ dosing FAQ

Is 5-Amino-1MQ injected?

No. It is a small molecule taken orally as a capsule, not a peptide reconstituted for injection.

How much is referenced per day?

Research-community sources cite oral doses in the tens of milligrams, commonly around 50-150 mg once daily, without clinical validation.

Is there an established human dose?

No. Evidence for its metabolic effects is from cell and animal studies, so any figure is a research reference only.

Why is it listed among peptides?

It is grouped with research peptides by convention, but chemically it is a small-molecule NNMT inhibitor rather than a peptide.

Sources

Categories: GLP-1 & Metabolic, Longevity & Cellular · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.